Showing results (451-460 of 537) with videos related to

Sort By:
Pageof 54
Acta Dermato-Venereologica|February 11, 2022
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance DataAlice B Gottlieb, Atul Deodhar, Iain B Mcinnes, et al.
BMJ Open|March 5, 2025
Long-term safety and efficacy of anti-GM-CSF otilimab in patients with rheumatoid arthritis: long-term extension of three phase 3 randomised trials (contRAst X)Michael E Weinblatt, Peter C Taylor, Iain B McInnes, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 22, 2011
MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritisMariola Kurowska-Stolarska, Stefano Alivernini, Lucy E Ballantine, et al.
Atherosclerosis|May 29, 2012
25-Hydroxyvitamin D is lower in deprived groups, but is not associated with carotid intima media thickness or plaques: results from pSoBidSusan Knox, Paul Welsh, Vladimir Bezlyak, et al.
RMD Open|October 19, 2022
A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseasesKastriot Kastrati, Daniel Aletaha, Gerd R Burmester, et al.
Pilot and Feasibility Studies|May 31, 2022
Gait rehabilitation for foot and ankle impairments in early rheumatoid arthritis: a feasibility study of a new gait rehabilitation programme (GREAT Strides)Gordon J Hendry, Lindsay Bearne, Nadine E Foster, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2008
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1Clive S McKimmie, Alasdair R Fraser, Chris Hansell, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 21, 2008
Hemopoietic cell expression of the chemokine decoy receptor D6 is dynamic and regulated by GATA1Clive S McKimmie, Alasdair R Fraser, Chris Hansell, et al.
Plos One|November 1, 2012
Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?Ashley M Miller, David Purves, Alex McConnachie, et al.
The Journal of Rheumatology|May 2, 2021
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic ArthritisProton Rahman, Christopher T Ritchlin, Philip S Helliwell, et al.
Pageof 54